Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Blood Volume Analyzer Market size was over USD 5.21 billion in 2024 and is projected to reach USD 16.36 billion by 2037, growing at around 9.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of blood volume analyzer is assessed at USD 5.62 billion.
The blood volume analyzer market is growing due to the increasing number of cardiovascular diseases leading to death. According to the World Health Organization (WHO), 17.9 million people die every year due to cardiovascular diseases worldwide. This high statistic rises the need for blood volume analyzers across the globe.

Blood Volume Analyzer Sector: Growth Drivers and Challenges
Growth Drivers
- Rising obesity level - According to a report published by the Centers for Disease Control and Prevention on Adult Obesity Facts, the medical cost of obesity is USD 173 billion annually in the USA. Moreover, there are many factors affecting the obesity rates such as males and females with college degrees being less obese in comparison to the less or uneducated ones. Obesity causes many diseases such as stroke, heart disorders, and cancer. Thus, with the rise of obesity and the associated risk of diseases such as CVD, blood volume analyzer market demand will also surge.
- Increase in cardiovascular diseases and blood disorders - Rapid changes in lifestyle behavior are increasing numerous serious medical conditions. In China, cardiovascular diseases are one of the leading causes of death. About 5 million people died in the year 2020 due to the increasing prevalence of high systolic blood pressure.
However, these diseases can be early diagnosed with the help of blood tests. Further, the blood volume analyzer measures blood volume in few minutes with accuracy. Due to systematic dysfunctions, the rate of blood volume changes and thus, it becomes crucial to regularly analyze blood volume to maintain an appropriate rate. - Technological advancements in healthcare - Advanced technology in healthcare has provided access to top-notch treatments. Additionally, the decrease in the cost value of new medical products is making appropriate medical care accessible to every patient.
Moreover, breakthrough analyzers such as blood gas analyzer that helps in determining the pH, carbon dioxide, oxygen and electrolytes, are best used for patients with serious conditions. Simultaneously, a blood volume analyzer helps in finding out red blood cells, plasma volume, and total blood volume which further helps in decreasing the risk factors associated with various diseases.
Challenges
- Lack of awareness - The new advanced medical devices require a proper understanding of the functions and benefits of the device. Unawareness about such devices due to unaffordability or unprofessionalism hinders the growth of the market.
- Unskilled labour - It is a major challenge to the blood volume analyzer market. Since, for proper utilization, appropriate training is required. The high cost of blood volume analyzers is a restraining factor in developing areas where the healthcare budget is limited.
Blood Volume Analyzer Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
9.2% |
Base Year Market Size (2024) |
USD 5.21 billion |
Forecast Year Market Size (2037) |
USD 16.36 billion |
Regional Scope |
|
Blood Volume Analyzer Segmentation
Type (Blood Enzyme Test, Blood Chemistry Test, Blood Clotting Test)
Blood enzyme test segment is estimated to capture blood volume analyzer market share of around 40% by the end of 2037. Enzymes are very necessary for the proper functioning of the body. Various enzymes are present in the human body which are crucial but at the same time disturbance in their measurement signifies signs of injury, operation, or infection.
A blood enzyme test is capable of measuring enzymes and proteins with the help of an enzyme marker. For instance, the CPK isoenzyme test, whose level should be 200 units per liter or less, is used to measure creatine phosphokinase in blood.
Application (Hospitals, Specialty Clinics, Diagnostic Centers)
In blood volume analyzer market, hospital segment is set to capture revenue share of around 30% by the end of 2037. Blood volume analyzers help hospitals and clinicians by quantifying plasma, blood cells, and intravascular blood, providing accurate information. The tests are cost-efficient and can be performed in less time.
Moreover, hospitals deal with patients with a variety of blood disorders and heart-related diseases, and therefore, the utilization of a blood volume analyzer is definitely a great choice. According to a report, the global cardiovascular treatment sector will generate a revenue of nearly USD 0.50 trillion by 2029.
Our in-depth analysis of the blood volume analyzer market includes the following segments:
Type |
|
Application |
|
Product |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportBlood Volume Analyzer Industry - Regional Synopsis
North America Market Forecast
North America industry is likely to account for largest revenue share of 42% by 2037. Since, the region has well-established infrastructure, health facilities, and skilled labor, which makes patients easily access highly advanced treatment techniques. In addition to this, increasing medical expenses are adding fuel to the blood volume analyzer market.
As per Health System Tracker, 20 million U.S adults have medical debt of USD 1,000 and still, some other medical debt figures cannot be accurately estimated. Moreover, medical expense is a persistent problem for many individuals and that’s why they choose cost-efficient medical services and products.
Further, in Canada heart diseases rank second in the list of most prevailing diseases and chronic disease management is becoming a priority task for the government. According to data from Canadian Chronic Disease Surveillance, around 2.6 million adults aged 20 or more are diagnosed with heart disease. This high number of heart disease cases in the region are predicted to raise the blood volume analyser market demand.
Asia Pacific Market Analysis
Asia Pacific region in blood volume analyzer market is set to showcase over 7% growth rate between 2024 and 2037 due to the increased cases of cancer and other blood disorders. In China, nearly 5 million new cases have been reported in 2022.
Cancer is reportedly a leading cause of death in Japan and is rapidly increasing due to the aging of the population. The most common types of cancers are related to the stomach, prostates, female breast, etc. According to the National Cancer Centre of Japan, nearly 1 million new cases of cancer have been witnessed in 2022.
Further, in Japan the market is witnessing growth as a result of the growing elderly population. This is because old aged people are more prone to diseases that may raise the need for blood volume analyzers.

Companies Dominating the Blood Volume Analyzer Landscape
- Siemens Healthineers
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott laboratories
- Sofina
- Quest Diagnostics
- Danaher Corporation
- Trividia Health
- F. Hoffman La Roche AG
- Bioamerica
- Becton and Dickinson
- Human
The blood volume analyzer market is dominated by key market players who are gaining traction in the market by providing advanced treatment solutions that offer precise detection and results.
In the News
- Siemens Healthineer launched an epoc blood analysis system that can be easily handheld, provides results in 30 seconds and can also be installed near the patient’s bedside. Further, this advanced epoc blood analysis system has improved the outcomes and as well as enhanced workflow in the healthcare sector.
- Premier and Quest Diagnostics announced a purchasing agreement where Premier can access steward solutions of Quest Diagnostics with negotiated rates and terms.
Author Credits: Radhika Pawar
- Report ID: 6149
- Published Date: Jan 03, 2025
- Report Format: PDF, PPT